Other Capital Market Information | 7 August 2019 11:51
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
|
Fresenius Medical Care AG & Co. KGaA / Correction notification: Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
– Share buy-back – 7 th Interim Report (correction notification) In the period from July 29, 2019 until and including August 2, 2019, a total of 63,746 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF): XETRA Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR
Chi-X Europe
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including August 2, 2019 therefore amounts to 1,534,327 shares. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
Bad Homburg v.d.H., August 5, 2019
07.08.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |